Sexual Dimorphism of Cancer-Associated Fibroblasts Governs Matrix and Vascular Organisation in Breast Cancer

Breast cancer is often discussed as a single disease, but biology tells a different story. The disease behaves differently in men and women, a fact that has long been recognized in how often it appears and how patients respond to treatment. Men are diagnosed far less frequently, yet when they are, the outcomes are often worse. This disparity suggests that the biological machinery driving the cancer in men is not simply a mirror image of the machinery in women. To understand why, scientists look beyond the cancer cells themselves to the neighborhood in which they live. This neighborhood, known as the tumor microenvironment, is a bustling community of various cell types that support, feed, and protect the tumor. Among the most abundant and influential residents are cells called cancer-associated fibroblasts. These cells act as the construction crew of the tumor, building a scaffold of proteins and fibers that holds the tissue together and shapes how the cancer grows, spreads, and interacts with the body's blood supply. For years, researchers assumed these support cells functioned the same way regardless of the patient's sex, but a new line of inquiry suggests that the sex of the patient fundamentally changes how these cells build their world.

A team of researchers set out to test whether these support cells, derived from breast tumors, behave differently depending on whether they came from a man or a woman. They started by collecting tissue samples from seven men and six women who had undergone surgery for breast cancer. From these samples, they isolated and grew the cancer-associated fibroblasts in the laboratory. Because men are rarely diagnosed with this disease, the team had to carefully preserve these cells by making them immortal, allowing them to grow for long periods without dying off, a step they also took with the female cells to ensure a fair comparison. Once they had healthy populations of these cells from both sexes, they began to observe how they functioned. The researchers looked at the genetic instructions inside the cells to see which genes were turned on or off. They found that the male and female cells were indeed running different programs. The genes active in the male cells pointed strongly toward building a dense, complex structure and organizing blood vessels, while the female cells followed a different path.

To see what these genetic differences meant in the real world, the scientists asked the cells to build their own scaffolds. They let the fibroblasts grow on glass slides and secrete their own matrix of proteins, creating a layer of material that mimics the environment inside a tumor. When they examined these layers under a microscope, the difference was striking. The material built by the male cells was significantly thicker and more densely packed than the material built by the female cells. The fibers in the male-built matrix were also more tightly aligned, creating a highly organized structure. In contrast, the matrix from the female cells was looser and less structured. This physical difference had immediate consequences for other cells trying to move across it. When the researchers placed breast cancer cells and blood vessel cells onto these matrices, they found that the cells stuck much more strongly to the dense, male-built scaffolds. The male matrix acted like a powerful magnet for these cells, encouraging them to adhere and stay put, whereas the female matrix did not hold them as tightly.

The story became even more complex when the researchers looked at how these cells influenced the formation of new blood vessels, a process critical for feeding a growing tumor. They placed blood vessel cells on top of layers of the fibroblasts to see how they would grow. When the blood vessel cells grew on top of the female fibroblasts, they formed long, slender, tube-like structures that resembled healthy, organized vessels. However, when they grew on top of the male fibroblasts, the result was different. The blood vessel cells formed shorter, stubbier tubes with many more branches, creating a network that was dense but disorganized. This suggests that the male fibroblasts drive the formation of a chaotic vascular network, one that might be less efficient at delivering oxygen and nutrients compared to the more orderly networks supported by female cells. To confirm these findings in a more realistic setting, the team used a sophisticated microfluidic device that allowed them to grow these cells together in a three-dimensional gel, simulating the conditions inside the body. Even in this complex environment, the pattern held: the presence of male fibroblasts led to less organized vascular networks, especially when cancer cells were also present.

The researchers also checked if these differences existed in actual human tissue. They examined slices of breast tumors from men and women that had been stained to highlight the collagen fibers in the tumor's support structure. Using advanced image analysis to measure the complexity and arrangement of these fibers, they found that the tumors from men had a significantly more complex and intricate internal structure in the areas where the cancer cells lived. This confirmed that the differences seen in the laboratory dishes were not just an artifact of cell culture but reflected real biological variations found in patients. The study did not find these differences in the tissue surrounding the tumor, suggesting that the sex-specific changes are driven by the interaction between the cancer and its immediate support cells.

These findings challenge the idea that breast cancer is a uniform disease that can be treated with a single approach for all patients. The research indicates that the biological sex of the patient influences the very architecture of the tumor, changing how the support cells build their environment and how that environment interacts with blood vessels and cancer cells. The male tumor environment appears to be built to be denser and more adhesive, potentially creating a more aggressive landscape for the disease. This does not mean that men and women have entirely different diseases, but rather that the same disease operates under different biological rules depending on the sex of the host. The authors suggest that future treatments for breast cancer need to take this into account. By understanding these sex-specific differences in the tumor's support system, doctors and scientists may be able to develop therapies that are tailored specifically to the unique biology of male breast cancer, potentially leading to better outcomes for a group of patients who have historically been overlooked in research. The work highlights that to truly understand cancer, one must look at the entire ecosystem of the tumor, including the hidden role that the sex of the patient plays in shaping its foundation.